EyePoint Pharmaceuticals, Inc.EYPTNASDAQ

Revenue (LTM)

$31M

-27.5% YoY

Net Income (LTM)

$-232M

-77.2% YoY

Free Cash Flow

$-243M

Revenue CAGR (5Y)

-1.8%

Marginsimproving

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	37	41↑12.1%	46↑11.1%	43↓6.0%	31↓27.5%
Gross Profit	29	33↑15.0%	41↑25.1%	40↓4.4%	29↓25.9%
Operating Income	-55	-100↓80.3%	-75↑24.7%	-146↓94.3%	-243↓66.9%
Net Income	-58	-102↓75.0%	-71↑30.8%	-131↓84.9%	-232↓77.2%
EBITDA	-50	-97↓92.7%	-69↑28.6%	-129↓87.3%	-243↓88.4%
EPS Diluted	-2.03	-2.74↓35.0%	-1.82↑33.6%	-2.32↓27.5%	-3.17↓36.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	179	96↓46.5%	281↑194.1%	100↓64.6%	102↑2.1%
Total Current Assets	238	173↓27.3%	345↑99.5%	383↑11.2%	329↓14.3%
Total Assets	263	180↓31.5%	355↑96.9%	418↑17.8%	364↓13.0%
Total Current Liabilities	24	35↑46.0%	63↑83.2%	49↓22.5%	37↓24.5%
Total Liabilities	79	84↑6.3%	89↑5.8%	82↓7.8%	58↓29.4%
Total Equity	184	96↓47.7%	266↑176.4%	337↑26.4%	306↓9.0%
Total Debt	39	46↑18.2%	5↓89.4%	22↑345.5%	21↓5.0%
Net Debt	-139	-49↑64.6%	-276↓460.7%	-78↑71.8%	-81↓4.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-50	-65↓29.8%	2↑102.9%	-126↓6832.1%	-240↓90.2%
Capital Expenditure	-0	-2↓1278.2%	-3↓62.0%	-4↓16.3%	-3↑19.1%
Free Cash Flow	-50	-67↓33.6%	-2↑97.6%	-130↓8001.9%	-243↓86.8%
Stock-Based Comp	7	14↑90.4%	12↓15.0%	37↑204.7%	28↓24.1%
Net Change in Cash	134	-83↓162.1%	186↑323.8%	-182↓197.8%	2↑101.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance